How Can NMAs and ITCs Add Value to HTAs?

The Evidence Base recently interviewed Dutch researcher Daan Reid. He shared his thoughts on health technology assessments (HTAs) and improving value assessments using indirect treatment comparisons (ITCs) and network meta-analyses (NMAs).

“In this feature, following participating in a Workshop at the International Society for Pharmacoeconomics and Outcomes Research’s 2021 virtual annual meeting (Virtual ISPOR 2021; 17–20 May), Daan Reid (University Medical Center Groningen, The Netherlands) discusses the GetReal Initiative.” Read more here.

(Source: Daan Reid, The Evidence Base, 6/16/21)